Correlation with PI-RADS Score and Gleason’s score of Prostate Cancer

Authors

  • Sandeep kumar sharma
  • Yogesh Kumar Yadav
  • Soniya Arunkumar Gupta
  • Kushagra Agarwal
  • Manoj kumar Gupta

DOI:

https://doi.org/10.52783/jns.v14.2295

Keywords:

prostate cancer, radical prostatectomy, staging, Gleason score, multi-parametric MRI, 3 Tesla, Spectroscopy, custom made Mold, histopathology

Abstract

Back Ground: The Prostate Imaging-Reporting and Data System (PI-RADS) is structured reporting scheme plays a crucial role in evaluating suspected prostate cancer using multiparametric MRI (mpMRI). PI-RADS provides a standardized framework for interpreting mpMRI scans of the prostate. It was developed collaboratively by the American College of Radiology (ACR), European Society of Urogenital Radiology (ESUR), and AdMeTech Foundation. The goal is to assess the likelihood of clinically significant prostate cancer based on imaging findings. It is scoring system, each suspicious lesion is assigned a score from 1 to 5, indicating the probability of clinically significant cancer.

Objective: The current study was dealt with derived the PIRADS score and observe the corelation with Gleason’s score.

Methods: Data Collection- Imaging Data was collected, stored and accessed and use of software for image analysis (e.g., radiomics tools).

Clinical Data: like patient demographics, clinical history, PSA levels were collected in patient information sheet

Histopathological Data: Recording of Gleason scores, tumor stages, and any relevant histological features.

Result:  The sensitivity of mpMRI with gleasons score was 85% and specificity was 70% with PPV of 78% and NPV of 80% in PI-RADS≥3 as compared to 90%, 85%, 88%, and 82% (sensitivity, specificity, PPV and NPV) of PI-RADS≥4.

Conclusion: The study demonstrates that mpMRI, particularly with a PI-RADS ≥4 threshold, provides a reliable and effective approach for detecting clinically significant prostate cancer. By improving sensitivity, specificity, and predictive values, mpMRI enhances diagnostic accuracy and supports better decision-making in patient management. Continued advancements in imaging technology and research will further refine the utility of mpMRI in the diagnosis and treatment of prostate cancer, ultimately leading to improved patient outcomes.

Downloads

Download data is not yet available.

References

Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–22. doi:10.1016/S0140-6736(16)32401-1.

Thompson, J. E., van Leeuwen, P. J., Moses, D., Shnier, R., Brenner, P., Delprado, W., & Stricker, P. D. (2016).The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer.The Journal of Urology, 195(5), 1428-1435.

Turkbey, B., Mani, H., Shah, V., Rastinehad, A. R., Bernardo, M., Pohida, T., & Choyke, P. L. (2011).Multiparametric 3T prostate magnetic resonance imaging to detect cancer: Histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.The Journal of Urology, 186(5), 1818-1824.

Epstein, J. I., et al. (2005). "Update on the Gleason grading system for prostate cancer: Results from an international consensus on Gleason grading." American Journal of Surgical Pathology. DOI: 10.1097/01.pas.0000157986.92872.b7.

Mohler, J. L., et al. (2019). "Prostate Cancer, Version 4.2019, NCCN Clinical Practice Guidelines in Oncology." Journal of the National Comprehensive Cancer Network (NCCN). DOI: 10.6004/jnccn.2019.0023.

Humphrey, P. A. (2004). "Gleason grading and prognostic factors in carcinoma of the prostate." Modern Pathology. DOI: 10.1038/modpathol.3800054.

Indian Council of Medical Research (ICMR): Resources from ICMR often provide insights into cancer trends and guidelines for various cancers, including prostate cancer.

WHO Cancer Database: The World Health Organization offers global and regional data on cancer epidemiology that may shed light on trends specific to India. Access: WHO Cancer Country Profile – India.

Bhambure, D. V., Yadav, D. S., S Patil , D. D., Gudur, D., & Gudur, D. (2025). Effect of Pre – operative structured exercise protocol on Postoperative Structural and Functional impairments in Modified Radical Mastectomy patients: A Randomized Control Trail. South Eastern European Journal of Public Health, 2347–2358. https://doi.org/10.70135/seejph.vi.5414

Weinreb, J. C., et al. (2016). "PI-RADS Prostate Imaging–Reporting and Data System: 2015, Version 2." European Urology, 69(1), 16–40. DOI: 10.1016/j.eururo.2015.08.052

Downloads

Published

2025-03-18

How to Cite

1.
kumar sharma S, Kumar Yadav Y, Arunkumar Gupta S, Agarwal K, Gupta M kumar. Correlation with PI-RADS Score and Gleason’s score of Prostate Cancer. J Neonatal Surg [Internet]. 2025 Mar. 18 [cited 2026 Mar. 4];14(6S):595-602. Available from: https://jneonatalsurg.com/index.php/jns/article/view/2295